The past few months have seen the approval of a pair of new drugs designed to treat obesity, Arena’s Belviq (see new now next in diaTribe #44) and Vivus’ Qsymia (see new...

How can the FDA change its view on drug approvals to give patients access to better therapies?

The artificial pancreas in peoples’ homes at the Annual Technologies & Treatments for Diabetes Meeting in Paris.

In August 2006, the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published a joint consensus statement on glucose...

This month, the American Journal of Preventive Medicine (AJPM) and the Robert Wood Johnson Foundation announced the start of The Childhood Obesity Challenge, a...

The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.

The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...

The diaTribe team had the opportunity to join primary care physicians from around the country at the Pri-Med East conference.

The World Health Organization (WHO) recently released its World Health Statistics 2o12 report, compiling data from 194 countries. The report estimates that about 9% of...

The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.

As it has for the past eight years, Take Control of Your Diabetes (TCOYD) is holding nationwide conferences on type 1 and type 2 diabetes . Notable speakers in the...

The development of a pen device for the once weekly GLP-1 agonist Bydureon (exenatide once-weekly) has hit a snag. Amylin (the drug’s manufacturer) had previously said...

Kelly reveals how you can help change the truly unacceptable care people with diabetes are receiving in prison.

In late November, Vivus launched its Get Started! Program , which gives potential users of its weight management medication Qsymia a chance to try the drug free for two...

Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.

Michelle Obama at the Partnership for a Healthier America’s Summit.

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

Many people with diabetes fear eye diseases leading to blindness. In diabetic macular edema (DME), the leading cause of blindness among working-age Americans (over 560,...

Kerri Morrone Sparling reveals how the Internet has built an all new kind of diabetes community.

On January 11, an advisory panel recommended that the FDA approve Johnson & Johnson’s SGLT-2 inhibitor, Invokana (canagliflozin). The panel voted 10-5 in favor of...